PX1 Research synthesizes research-grade Bronchogen for laboratory investigation into bronchial epithelial defense mechanisms and mucosal tissue dynamics. Manufactured domestically under strict quality standards, our Bronchogen features lot-specific HPLC and mass spectrometry verification to support rigorous in vitro and preclinical research protocols.
PX1 Research synthesizes research-grade Bronchogen for laboratory investigation into bronchial epithelial defense mechanisms and mucosal tissue dynamics. Manufactured domestically under strict quality standards, our Bronchogen features lot-specific HPLC and mass spectrometry verification to support rigorous in vitro and preclinical research protocols.
In preclinical model systems, Bronchogen (Ala-Asp-Glu-Leu) is studied for its ability to regulate bronchial epithelial cell homeostasis, enhance cellular defense against oxidative stress, and modulate inflammatory cytokine expression in respiratory tissues. As a professional manufacturer, PX1 Research supplies USA-synthesized Bronchogen featuring lot-specific third-party COAs, >98% HPLC purity verification, and strict endotoxin testing for qualified laboratory research.
When evaluating a professional manufacturer for research peptides, institutional laboratories require validated chemical synthesis, robust analytical verification, and complete batch traceability. PX1 Research addresses these requirements by producing high-purity sequence-verified compounds designed exclusively for in vitro assay design, cell culture experimentation, and animal tissue models.
Bronchogen is a synthetic short bioregulatory tetrapeptide composed of four amino acids: L-alanyl-L-alpha-aspartyl-L-alpha-glutamyl-L-leucine (sequence: Ala-Asp-Glu-Leu or AEDL). Originating from the peptide bioregulation framework developed to investigate tissue-specific chromatin interactions, short peptide sequences like AEDL are hypothesized to penetrate cellular and nuclear membranes to interact with histone proteins and specific DNA sequences.
With a precise molecular weight of approximately 460.48 g/mol, Bronchogen's small structure permits high solubility in standard aqueous buffers used in research laboratories. Understanding the structural dynamics of this short sequence is essential for primary investigator research aiming to map nuclear targeting mechanisms, gene expression modulation, and cellular aging markers within pulmonary tissue cultures. PX1 Research maintains strict control over the peptide assembly process via solid-phase peptide synthesis (SPPS), ensuring correct sequence fidelity and chemical identity.
Preclinical studies suggest that Bronchogen exerts tissue-specific effects on bronchial epithelial cellular populations. In vitro assays using human bronchial epithelial cells (such as BEAS-2B or primary human airway epithelial cultures) indicate that exposure to Bronchogen modulates the expression of genes associated with cell differentiation, barrier tight-junction proteins (e.g., zonula occludens-1 and occludin), and mucociliary clearance integrity.
In animal models of acute lung inflammation and oxidative injury—such as lipopolysaccharide (LPS)-induced pulmonary challenge in rodents—preclinical data demonstrate that Bronchogen administration correlates with decreased pro-inflammatory mediator levels, including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). Furthermore, researchers investigating cellular defense mechanisms note increased expression of antioxidant enzymes such as superoxide dismutase (SOD) and catalase. These preclinical observations highlight Bronchogen's potential utility in models assessing mucosal repair, bronchial repair kinetics, and cellular survival under toxicological or inflammatory stress. Investigators interested in deeper physiological pathways can review related studies in our comprehensive research hub.
To contextualize Bronchogen within peptide bioregulator research, laboratories frequently analyze it alongside other synthetic short-chain peptides designed for specific organ-system targets. While Bronchogen focuses specifically on bronchial mucosal and epithelial defense pathways, related bioregulatory compounds demonstrate distinct tissue specificity and systemic immune activity.
For instance, vilon (Lys-Glu) is widely studied for its generalized immunomodulatory effects and stimulation of splenic lymphocyte proliferation in preclinical models. Similarly, thymogen (Glu-Trp) is investigated for T-cell differentiation and thymic functional recovery under immunodeficient states. In contrast, epitalon (Ala-Glu-Asp-Gly) is evaluated primarily for pineal gland regulation, telomerase activity induction, and neuroendocrine modulation. Examining these compounds side-by-side allows researchers to construct targeted comparative studies evaluating tissue-specific peptide signaling versus systemic immunomodulatory responses.
Securing reliable scientific outcomes requires peptide compounds that are free from synthesis artifacts, unreacted side products, and biological contaminants. PX1 Research adheres to rigorous quality control frameworks, operating through GMP-compliant manufacturing facilities and ISO 17025-accredited testing laboratories to guarantee reproducible quality across every batch.
Every production lot of Bronchogen 10mg undergoes comprehensive analytical verification before release. This includes reversed-phase high-performance liquid chromatography (RP-HPLC) to verify chemical purity exceeding 98%, alongside electrospray ionization mass spectrometry (ESI-MS) to confirm exact mass identity. Certificates of Analysis (COAs) detailing lot-specific chromatograms and mass spectra are publicly available for researcher verification prior to project execution.
In cell culture assays evaluating inflammatory responses, endotoxin contamination (lipopolysaccharides derived from Gram-negative bacterial outer membranes) can severely compromise data integrity. Spurious endotoxin presence induces innate immune activation via Toll-like receptor 4 (TLR4), clouding experimental observations regarding a peptide's true baseline activity.
To protect in vitro cell culture validity, PX1 Research subjects all peptide lots to quantitative Limulus Amebocyte Lysate (LAL) testing. Our rigorous purification processes maintain endotoxin levels below 0.01 EU/mg, preventing background inflammatory artifact in delicate bronchial cell lines and organoid cultures. Research teams designing sensitive transcriptomic or proteomic assays can consult our detailed endotoxin testing standards for peptides for specific baseline metrics.
PX1 Research supplies Bronchogen as a sterile, lyophilized cake designed to maintain maximal chemical stability during ambient temperature shipping. Proper handling procedures within the laboratory environment are essential to ensure structural integrity and sample stability prior to testing.
Upon arrival, lyophilized Bronchogen should be stored at -20°C or -80°C for long-term preservation. When preparing stock solutions for laboratory experimentation, the peptide should be reconstituted using sterile bacteriostatic water, sterile phosphate-buffered saline (PBS, pH 7.4), or endotoxin-free water under a certified laminar flow biosafety cabinet. Once reconstituted, stock solutions should be aliquoted into single-use polypropylene tubes to avoid repeated freeze-thaw cycles, which can induce peptide degradation. Reconstituted aliquots remain stable at 4°C for short-term use (up to 7 days) or at -80°C for extended experimental protocols. For full handling parameters, refer to our peptide reconstitution guide.
PX1 Research serves as a trusted domestic supply partner for academic institutions, biotechnology companies, and contract research organizations (CROs). Operating directly out of state-of-the-art facilities in California and Arizona, we eliminate international customs delays, cold-chain breakdowns, and regulatory clearance bottlenecks common with offshore vendors.
For high-throughput screening initiatives or long-term animal studies requiring consistent bulk material, our wholesale procurement program offers dedicated account management, custom batch synthesis options, and standardized bulk lot reservation. Orders placed Monday through Friday ship same-day, ensuring fast delivery schedules for critical research workflows.
What is the primary scientific focus of Bronchogen research?
Bronchogen (Ala-Asp-Glu-Leu) is studied primarily in preclinical models to investigate bronchial epithelial cell defense, mucosal integrity, antioxidant response mechanisms, and inflammatory cytokine modulation in lung tissue.
Is Bronchogen supplied by PX1 Research intended for human clinical use?
No. Bronchogen supplied by PX1 Research is strictly for in vitro laboratory research, cellular assays, and preclinical animal models. It is not intended for human or veterinary medical use, therapy, or administration.
How does PX1 Research verify the purity of Bronchogen?
Each lot of Bronchogen undergoes third-party verification using Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) to confirm >98% purity, alongside Mass Spectrometry (MS) to verify molecular weight and identity.
What endotoxin levels are guaranteed in PX1 Bronchogen lots?
PX1 Research conducts quantitative LAL assay testing on all research peptides to ensure endotoxin levels remain below strictly monitored research thresholds (<0.01 EU/mg), preventing cellular culture contamination.
What solvent is recommended for reconstituting Bronchogen in laboratory setups?
Bronchogen is readily soluble in sterile endotoxin-free water or phosphate-buffered saline (PBS, pH 7.4). Solubilization should take place under sterile conditions in a biosafety cabinet.
How should Bronchogen be stored upon receipt in the lab?
Lyophilized Bronchogen should be stored at -20°C or -80°C upon receipt. Reconstituted solutions should be divided into single-use aliquots and kept at -80°C to prevent freeze-thaw degradation.
Where are PX1 Research peptides manufactured and shipped from?
PX1 Research peptides are manufactured in US-based GMP-compliant facilities and shipped directly from fulfillment centers located in California and Arizona, offering same-day M-F dispatch.
How does Bronchogen compare to other bioregulatory peptides like Vilon?
While Bronchogen specifically targets bronchial tissue models and epithelial defense mechanisms, Vilon (Lys-Glu) is typically studied for systemic immunomodulatory pathways and T-cell activation.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.